By Bachem AG
To get in touch with Bachem brings advanced insights to Iberian Peptide Meeting Madrid, simply fill out the form below.
Subscribe to Supplier
Bachem brings advanced insights to Iberian Peptide Meeting Madrid
Bubendorf, Switzerland: –Peptide technology specialist Bachem AG is returning to the latest Iberian Peptide Meeting (XVII EPI) in Madrid to present its latest ‘Pioneering Partner for Peptides’ offers, products and solutions.Bachem also attended the previous Iberian Peptide Meeting, held in 2018 in Barcelona and is a sponsor of the biennial event.
Range of disciplines
The Bachem team in Madrid, including Sales Service specialist Isabelle Sutter and Custom Synthesis Sales Manager Dr. Stéphanie Henriot, will share details of the Swiss-based company’s latest research projects, spanning a range of disciplines, from basic synthetic, structural, biophysical and computational studies, to pharmaceutical, material or food science applications.
Peptides are one of the core business areas for Bachem and the conference provides a valuable opportunity to share knowledge with leading specialists who are involved in the world of amino acids, peptides and proteins.
The Bachem Group is the world’s only full service provider of peptides and provides a full range of other services to the pharma and biotech industries.
Under its banner Pioneering Partner for Peptides, Bachem specializes in the process development and manufacture of peptides and complex organic molecules as active pharmaceutical ingredients (APIs).
A comprehensive catalog of innovative biochemicals for research and exclusive custom syntheses for research labs complete its service portfolio.
Headquartered in Switzerland with subsidiaries in Europe, the US and Asia, the group has a global reach and shows total commitment to quality, innovation and partnership to its customers worldwide.
Bachem prioritizes continuous investment in R&D on chemistries and technologies as crucial for future success. Its ever-increasing knowledge of complex proteins and peptides derives from ongoing research in proteomics, as well as progress in mass spectrometry, synthesis and ligation technologies, complemented by collaboration with external research institutions.
Bachem has six production sites in the U.S. and in Europe along with research level production and full cGMP manufacturing facilities on both continents. These provide capacity to produce APIs, key intermediates, small molecule generics, new chemical entities (NCEs) and finished dosage forms at preclinical, clinical and production scales.
About Iberian Peptide Meeting 2020
Founded in 1988, The Iberian Peptide Meeting (EPI, Encuentro Peptídico Ibérico) is a long-established biennial gathering of specialists from the Iberian Peninsula covering a broad range of peptide-focused disciplines, from chemical, structural or biophysical aspects to pharmaceutical or biomaterial applications.
The 17th Meeting (EPI XVII) is a three day event opening February 5 at the Rocasolano Institute of Physical Chemistry (IQFR) in Madrid.
EPI XVII will bring together highly experienced senior scientists from Portugal, Spain and other European countries to participate in invited and plenary lectures, including opportunities for post-graduate and post-doctoral students and junior researchers to deliver selected poster presentations.
The meeting is organized by the Iberian Peptide community, affiliated with the European Peptide Society (EPS) with further information at: http://epi2020.iqfr.csic.es/